AAAAAA

   
Results: 1-15 |
Results: 15
TRENDS IN CARDIOVASCULAR RISK-FACTORS IN EAST-GERMANY - 3 INDEPENDENTPOPULATION STUDIES AS PART OF THE PROJECT MONICA EAST-GERMANY
Authors: HEINEMANN LAJ GARBE E CLASSEN E WILLICH SN BARTH W THIEL C
Citation: Laj. Heinemann et al., TRENDS IN CARDIOVASCULAR RISK-FACTORS IN EAST-GERMANY - 3 INDEPENDENTPOPULATION STUDIES AS PART OF THE PROJECT MONICA EAST-GERMANY, Deutsche Medizinische Wochenschrift, 123(30), 1998, pp. 889-895
THROMBOEMBOLIC STROKE IN YOUNG-WOMEN - A EUROPEAN CASE-CONTROL STUDY ON ORAL-CONTRACEPTIVES
Authors: HEINEMANN LAJ LEWIS MA SPITZER WO THOROGOOD M GUGGENMOOSHOLZMANN I BRUPPACHER R
Citation: Laj. Heinemann et al., THROMBOEMBOLIC STROKE IN YOUNG-WOMEN - A EUROPEAN CASE-CONTROL STUDY ON ORAL-CONTRACEPTIVES, Contraception, 57(1), 1998, pp. 29-37
SCIENTIFIC PROBLEMS WITH A NONCAUSAL ARTIFACT
Authors: HEINEMANN LAJ SPITZER WO WINKLER UH
Citation: Laj. Heinemann et al., SCIENTIFIC PROBLEMS WITH A NONCAUSAL ARTIFACT, American journal of obstetrics and gynecology, 178(5), 1998, pp. 1105-1106
SAFETY OF CYPROTERONE-ACETATE - REPORT OF ACTIVE SURVEILLANCE
Authors: HEINEMANN LAJ WILLSHAHAB L VANKESTEREN P GOOREN LJG QUAST A PIETSCH H KONRAD N HELGE H GRUTERS A KNAPPE G VENTZ M PRANGE G UBELHACK R BANASCHAK K CAVALLARI C MACRELLI S HINKEL GK JUSTUS B SAREMBE B ABUSCHENKO E MOESLER T SCHINDLER AE REGIDUR PA MADJIDIAN K BRAENDLE LW KLEINKAUFHOUCKEN A HORN HJ MICHEL W MORLOT M VEISMANN S ZIEGLER R KREMPIEN R ALENFELD F HEINRICH U SIPPELL WG WILLE R LASCHET R ALEXANDER H GLANDER HJ SCHWARZE I HOEPFFNER W DIEDRICH K SCHILL T HEISE HR LEHNERT H SCHLICHTHAAR H WEISE W GERLOFF C NICKEL I BURMANNREUTER H KRAUSE W FLOHR J PLEWIG G WOLF H SCHWARZ HP BECKER A SCHMIDT C SIEGELALMASRY E MIX M OTTERMANN B RANKE MB GRAUER ML TELLER W HOMOKI J WALDHAUSER F KAISER E BALJER E EIDEN R OTT F
Citation: Laj. Heinemann et al., SAFETY OF CYPROTERONE-ACETATE - REPORT OF ACTIVE SURVEILLANCE, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 169-178
CASE-CONTROL STUDY OF ORAL-CONTRACEPTIVES AND RISK OF THROMBOEMBOLIC STROKE - RESULTS FROM INTERNATIONAL STUDY ON ORAL-CONTRACEPTIVES AND HEALTH OF YOUNG-WOMEN
Authors: HEINEMANN LAJ LEWIS MA THOROGOOD M SPITZER WO GUGGENMOOSHOLZMANN I BRUPPACHER R BERGMAN U BRECKWOLDT M KEMPER F LELORIER J MACLEOD S MACRAE K RAY W SCHLESSELMAN J CONCIN H STARK G PFEIFFER K WEITGASSER R BEGAUD B BOISSEL B HAERTING J LAUTENSCHLAEGER F PUSCHEL K HOFFMANN F ROBRA BP LUSTERMANN M SCHULZKI I BOETHIG S GUTZWILLER F DECAESTECKER L MCCOLLUM C HANNAFORD P MANN R KUHLHABICH D KLINDWORTH C ASSMANN A
Citation: Laj. Heinemann et al., CASE-CONTROL STUDY OF ORAL-CONTRACEPTIVES AND RISK OF THROMBOEMBOLIC STROKE - RESULTS FROM INTERNATIONAL STUDY ON ORAL-CONTRACEPTIVES AND HEALTH OF YOUNG-WOMEN, BMJ. British medical journal, 315(7121), 1997, pp. 1502-1504
LOWERED RISK OF DYING OF HEART-ATTACK WITH 3RD-GENERATION PILL MAY OFFSET RISK OF DYING OF THROMBOEMBOLISM
Authors: LEWIS MA SPITZER WO HEINEMANN LAJ MACRAE KD BRUPPACHER R
Citation: Ma. Lewis et al., LOWERED RISK OF DYING OF HEART-ATTACK WITH 3RD-GENERATION PILL MAY OFFSET RISK OF DYING OF THROMBOEMBOLISM, BMJ. British medical journal, 315(7109), 1997, pp. 679-680
ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM
Authors: LEWIS MA HEINEMANN LAJ
Citation: Ma. Lewis et Laj. Heinemann, ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM, Lancet, 349(9065), 1997, pp. 1621-1622
POSSIBILITIES AND LIMITATIONS OF EPIDEMIO LOGY - STEROID-HORMONES ANDVENOUS THROMBOSIS
Authors: HEINEMANN LAJ
Citation: Laj. Heinemann, POSSIBILITIES AND LIMITATIONS OF EPIDEMIO LOGY - STEROID-HORMONES ANDVENOUS THROMBOSIS, Der Gynakologe, 30(4), 1997, pp. 296-304
ORAL-CONTRACEPTIVES AND LIVER-CANCER - RESULTS OF THE MULTICENTER INTERNATIONAL LIVER-TUMOR STUDY (MILTS)
Authors: HEINEMANN LAJ DOMINH T GUGGENMOOSHOLZMANN I THIEL C GARBE E FEINSTEIN AR THOMAS D BRECHOT C SPITZER WO WATANABE S BERAL V MEIRIK O
Citation: Laj. Heinemann et al., ORAL-CONTRACEPTIVES AND LIVER-CANCER - RESULTS OF THE MULTICENTER INTERNATIONAL LIVER-TUMOR STUDY (MILTS), Contraception, 56(5), 1997, pp. 275-284
THE USE OF ORAL-CONTRACEPTIVES AND THE OCCURRENCE OF ACUTE MYOCARDIAL-INFARCTION IN YOUNG-WOMEN - RESULTS FROM THE TRANSNATIONAL STUDY ON ORAL-CONTRACEPTIVES AND THE HEALTH OF YOUNG-WOMEN
Authors: LEWIS MA HEINEMANN LAJ SPITZER WO MACRAE KD BRUPPACHER R
Citation: Ma. Lewis et al., THE USE OF ORAL-CONTRACEPTIVES AND THE OCCURRENCE OF ACUTE MYOCARDIAL-INFARCTION IN YOUNG-WOMEN - RESULTS FROM THE TRANSNATIONAL STUDY ON ORAL-CONTRACEPTIVES AND THE HEALTH OF YOUNG-WOMEN, Contraception, 56(3), 1997, pp. 129-140
ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM - ACQUIRED APC RESISTANCE
Authors: SCHRAMM W HEINEMANN LAJ
Citation: W. Schramm et Laj. Heinemann, ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM - ACQUIRED APC RESISTANCE, British Journal of Haematology, 98(2), 1997, pp. 491-491
IS THERE A RISK PROFILE FOR THE 3RD-GENER ATION OVULATION INHIBITORS
Authors: HEINEMANN LAJ
Citation: Laj. Heinemann, IS THERE A RISK PROFILE FOR THE 3RD-GENER ATION OVULATION INHIBITORS, Deutsche Medizinische Wochenschrift, 121(34-35), 1996, pp. 1037-1039
3RD-GENERATION ORAL-CONTRACEPTIVES AND RISK OF VENOUS THROMBOEMBOLIC DISORDERS - AN INTERNATIONAL CASE-CONTROL STUDY
Authors: SPITZER WO LEWIS MA HEINEMANN LAJ THOROGOOD M MACRAE KD
Citation: Wo. Spitzer et al., 3RD-GENERATION ORAL-CONTRACEPTIVES AND RISK OF VENOUS THROMBOEMBOLIC DISORDERS - AN INTERNATIONAL CASE-CONTROL STUDY, BMJ. British medical journal, 312(7023), 1996, pp. 83-88
3RD-GENERATION ORAL-CONTRACEPTIVES AND RISK OF MYOCARDIAL-INFARCTION - AN INTERNATIONAL CASE-CONTROL STUDY
Authors: LEWIS MA SPITZER WO HEINEMANN LAJ MACRAE KD BRUPPACHER R THOROGOOD M
Citation: Ma. Lewis et al., 3RD-GENERATION ORAL-CONTRACEPTIVES AND RISK OF MYOCARDIAL-INFARCTION - AN INTERNATIONAL CASE-CONTROL STUDY, BMJ. British medical journal, 312(7023), 1996, pp. 88-90
THE INCREASED RISK OF VENOUS THROMBOEMBOLISM AND THE USE OF 3RD GENERATION PROGESTAGENS - ROLE OF BIAS IN OBSERVATIONAL RESEARCH
Authors: LEWIS MA HEINEMANN LAJ MACRAE KD BRUPPACHER R SPITZER WO
Citation: Ma. Lewis et al., THE INCREASED RISK OF VENOUS THROMBOEMBOLISM AND THE USE OF 3RD GENERATION PROGESTAGENS - ROLE OF BIAS IN OBSERVATIONAL RESEARCH, Contraception, 54(1), 1996, pp. 5-13
Risultati: 1-15 |